- Home
- SNT vs IOBT Comparison
SNT vs IOBT Comparison
Compare SNT & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- IOBT
- Stock Information
- Founded
- SNT 1965
- IOBT 2014
- Country
- SNT Canada
- IOBT Denmark
- Employees
- SNT N/A
- IOBT N/A
- Industry
- SNT Telecommunications Equipment
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- SNT Telecommunications
- IOBT Health Care
- Exchange
- SNT Nasdaq
- IOBT Nasdaq
- Market Cap
- SNT 95.2M
- IOBT 79.7M
- IPO Year
- SNT 1993
- IOBT 2021
- Fundamental
- Price
- SNT $3.96
- IOBT $1.35
- Analyst Decision
- SNT
- IOBT Strong Buy
- Analyst Count
- SNT 0
- IOBT 3
- Target Price
- SNT N/A
- IOBT $9.33
- AVG Volume (30 Days)
- SNT 80.6K
- IOBT 229.4K
- Earning Date
- SNT 05-27-2025
- IOBT 05-14-2025
- Dividend Yield
- SNT N/A
- IOBT N/A
- EPS Growth
- SNT N/A
- IOBT N/A
- EPS
- SNT 0.18
- IOBT N/A
- Revenue
- SNT $36,690,000.00
- IOBT N/A
- Revenue This Year
- SNT N/A
- IOBT N/A
- Revenue Next Year
- SNT N/A
- IOBT N/A
- P/E Ratio
- SNT $22.00
- IOBT N/A
- Revenue Growth
- SNT 8.36
- IOBT N/A
- 52 Week Low
- SNT $1.34
- IOBT $0.66
- 52 Week High
- SNT $4.29
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- SNT 58.27
- IOBT 52.94
- Support Level
- SNT $3.65
- IOBT $1.45
- Resistance Level
- SNT $3.95
- IOBT $1.57
- Average True Range (ATR)
- SNT 0.25
- IOBT 0.15
- MACD
- SNT -0.02
- IOBT -0.01
- Stochastic Oscillator
- SNT 48.44
- IOBT 42.62
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.